Conference Call with Ipca Laboratories Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals company Ipca Laboratories announced Q1FY26 results Revenue from Operations: Rs 2,308.85 crore compared to Rs 2,092.63 crore during Q1FY25, a change of 10%. EBITDA: Rs 424.58 crore compared to Rs 387.49 crore during Q1FY25, change 10%. PBT: Rs 234.42 crore compared to Rs 198.98 crore during Q1FY25, change 18%. PAT: Rs 233.21 crore compared to Rs 192.24 crore during Q1FY25, change 21%. EPS: Rs 9.19 for Q1FY26. Result PDF